Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an announcement.
Integral Diagnostics Limited reported a 9.3% increase in revenues from ordinary activities to $252.872 million for the half year ended December 31, 2024. Despite a reported loss of $396,000 attributable to owners, this reflects a significant reduction from the previous period’s loss of $66.756 million, primarily due to an impairment loss recognized earlier. The company declared a fully franked interim dividend of 2.5 cents per share, payable on April 7, 2025, and announced the acquisition of Capitol Health Limited, which may impact its market positioning and operational scale.
More about Integral Diagnostics Ltd.
Integral Diagnostics Limited operates in the healthcare industry, specializing in diagnostic imaging services. The company focuses on providing comprehensive imaging solutions, including radiology and medical imaging services, to various healthcare sectors.
YTD Price Performance: -0.69%
Average Trading Volume: 1,003,533
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$1.07B
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.